Kilitch Drugs (India) Ltd (KILITCH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "183.00",
    "chg": 1.95,
    "chgp": "1.08%",
    "dir": 1,
    "prev_price": "181.05",
    "mcapval": "633.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE729D01010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.21 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-hold-as-financial-and-technical-trends-improve-4002096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_mojoScore_4002096.png",
        "date": "2026-05-21 08:01:16",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and evolving market trends have contributed to a more balanced outlook, signalling cautious optimism for investors in this pharmaceuticals micro-cap."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4002010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_technicaldot_4002010.png",
        "date": "2026-05-21 08:00:26",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.8% daily gain to ₹184.15, coupled with a significant upgrade in its Mojo Grade from Sell to Hold, signals a cautious optimism among investors amid mixed market conditions."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts to Attractive Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-attractive-amid-market-volatility-3997659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_valuationdot_3997659.png",
        "date": "2026-05-19 08:00:14",
        "description": "Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential inflection point for investors. With its price-to-earnings (P/E) ratio easing to 19.44 and price-to-book value (P/BV) at 2.10, the pharmaceutical company is now trading at more compelling levels relative to its historical averages and peer group, despite a recent 10.88% surge in its share price."
      },
      {
        "title": "Kilitch Drugs Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3988480",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_mojoScore_3988480.png",
        "date": "2026-05-13 08:00:51",
        "description": "Kilitch Drugs (India) Ltd has been downgraded from a Sell to a Strong Sell rating as of 12 May 2026, reflecting deteriorating technical indicators and disappointing financial performance. The micro-cap pharmaceutical company’s Mojo Score has fallen to 26.0, signalling heightened risk for investors amid a challenging market environment and weak operational metrics."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3988432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_technicaldot_3988432.png",
        "date": "2026-05-13 08:00:44",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and mixed signals from momentum oscillators, paints a challenging outlook for investors amid a micro-cap pharmaceutical sector environment."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-3965345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_technicaldot_3965345.png",
        "date": "2026-04-28 08:00:42",
        "description": "Kilitch Drugs (India) Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day gain of 2.29% to close at ₹154.20, the micro-cap pharmaceutical company continues to face headwinds as key technical indicators present a mixed picture, reflecting cautious investor sentiment amid broader market volatility."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3963488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_technicaldot_3963488.png",
        "date": "2026-04-27 08:00:19",
        "description": "Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. The stock’s recent price action, combined with key technical indicators such as MACD, RSI, and moving averages, signals increasing downside pressure amid a challenging market environment."
      },
      {
        "title": "Kilitch Drugs Gains 11.58%: 4 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-1158-4-key-factors-driving-the-weekly-rally-3963307",
        "imagepath": "",
        "date": "2026-04-26 14:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.134.90, marginally down amid flat Sensex</p>\n                    <p><strong>21 Apr:</strong> Downgrade to Strong Sell announced; stock surges 5.86%</p>\n                    <p><strong>22 Apr:</strong> Valuation shifts to attractive; stock jumps 7.88%</p>\n                    <p><strong>23 Apr:</strong> Upgrade to Sell and technical momentum shift; intraday rally of 8.16%</p>\n                    <p><strong>24 Apr:</strong> Profit-taking leads to 5.75% decline; week closes at Rs.150.75</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-..."
      },
      {
        "title": "Kilitch Drugs Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-sell-a-detailed-analysis-of-quality-valuation-financial-trend-and-technicals-3958355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KilitchDrugsInd_mojoScore_3958355.png",
        "date": "2026-04-23 08:01:09",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 22 April 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing financial challenges. The pharmaceutical micro-cap’s recent price surge of 8.16% to ₹154.45 has contributed to this reassessment, signalling a shift in market sentiment and underlying fundamentals."
      }
    ],
    "total": 15,
    "sid": "189669",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "We are hereby submitting annual secretarial compliance report for the year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-May-2026",
      "details": "We are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2026",
      "datetime": "07-May-2026",
      "details": "Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs Upgraded to Hold as Financial and Technical Trends Improve

2026-05-21 08:01:16

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and evolving market trends have contributed to a more balanced outlook, signalling cautious optimism for investors in this pharmaceuticals micro-cap.

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-21 08:00:26

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.8% daily gain to ₹184.15, coupled with a significant upgrade in its Mojo Grade from Sell to Hold, signals a cautious optimism among investors amid mixed market conditions.

Kilitch Drugs Valuation Shifts to Attractive Amid Market Volatility

2026-05-19 08:00:14

Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential inflection point for investors. With its price-to-earnings (P/E) ratio easing to 19.44 and price-to-book value (P/BV) at 2.10, the pharmaceutical company is now trading at more compelling levels relative to its historical averages and peer group, despite a recent 10.88% surge in its share price.

Kilitch Drugs Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-05-13 08:00:51

Kilitch Drugs (India) Ltd has been downgraded from a Sell to a Strong Sell rating as of 12 May 2026, reflecting deteriorating technical indicators and disappointing financial performance. The micro-cap pharmaceutical company’s Mojo Score has fallen to 26.0, signalling heightened risk for investors amid a challenging market environment and weak operational metrics.

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-05-13 08:00:44

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and mixed signals from momentum oscillators, paints a challenging outlook for investors amid a micro-cap pharmaceutical sector environment.

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-28 08:00:42

Kilitch Drugs (India) Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day gain of 2.29% to close at ₹154.20, the micro-cap pharmaceutical company continues to face headwinds as key technical indicators present a mixed picture, reflecting cautious investor sentiment amid broader market volatility.

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-04-27 08:00:19

Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. The stock’s recent price action, combined with key technical indicators such as MACD, RSI, and moving averages, signals increasing downside pressure amid a challenging market environment.

Kilitch Drugs Gains 11.58%: 4 Key Factors Driving the Weekly Rally

2026-04-26 14:00:04

Key Events This Week 20 Apr: Stock opens at Rs.134.90, marginally down amid flat Sensex 21 Apr: Downgrade to Strong Sell announced; stock surges 5.86% 22 Apr: Valuation shifts to attractive; stock jumps 7.88% 23 Apr: Upgrade to Sell and technical momentum shift; intraday rally of 8.16% 24 Apr: Profit-taking leads to 5.75% decline; week closes at Rs.150.75 Week Open<div class="stat-...

Kilitch Drugs Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals

2026-04-23 08:01:09

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 22 April 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing financial challenges. The pharmaceutical micro-cap’s recent price surge of 8.16% to ₹154.45 has contributed to this reassessment, signalling a shift in market sentiment and underlying fundamentals.

View All News